Entrepreneur Investor in Diagnostics and Therapeutics
The founder and executive chairman of Progenity, a genetic testing company, Dr. Harry Stylli draws on more than three decades of experience in healthcare research. He previously served as president and CEO of CovX Pharmaceuticals and held several senior executive roles at Aurora Biosciences, both of which he guided to successful acquisition by major pharmaceutical companies. Subsequently, Dr. Harry Stylli served as president, CEO, and director of Xencor, overseeing its transition from tools manufacturing to biopharmaceutical development
Concurrent with his work at Progenity, Dr. Harry Stylli is the chairman of OncoCellMDx Inc., which develops and brings to market innovative testing systems. The company makes use of proprietary technology licensed through Harvard Medical School to produce advanced oncology and non-oncology testing. Since Dr. Stylli assumed leadership of OncoCellMDx, the company has continued to provide clinical teams with tools that support informed medical decision-making.
To date, the company has developed a number of unique platforms, including an immunogenomic analysis that powers the evaluation of cancers. This particular tool, which is appropriate for laboratory developed test (LDT) and in vitro diagnostic (IVD) pathways, identifies and evaluates transcription levels between non-phagocytic and phagocytic lymphocytes. Through a combination of the firm’s unique technology and advanced learning algorithms, the platform enables physicians to grade tumors and distinguish aggressive disease from benign tumors or the absence of pathology.
In his work with OncoCellMDx, as well as through his leadership of Progenity, Dr. Harry Stylli facilitates the development of tools that provide physicians and their patients with key data. He also supports advancements in medical science through his philanthropic activities. An advisory board member with the Duke Institute for Brain Sciences, Dr. Stylli also serves as honorary director for the ABC Youth Foundation.
- This Is How Gene Therapy Could Cure Alzheimer’s Disease: The Facts You Need to Know - The field of gene therapy is still very much in the formative stages. Clinical trials are reserved for only the most serious cases where other treatment has failed. Nevertheless, this experimental treatment offers great hope in tackling a range of serious, and previously incurable diseases. In this article, we look at the application of gene … Continue reading This Is How Gene Therapy Could Cure Alzheimer’s Disease: The Facts You Need to Know
- What Are the Greatest Breakthroughs in Genetics to Date? - Modern genetics sprang to life in the 1800s, when scientists began to understand how hereditary traits are passed on. We take a look at some of the biggest advancements in the world of genetics to date, from Mendel’s rules of heredity to the US-led Human Genome Project, when the human genome was first sequenced at … Continue reading What Are the Greatest Breakthroughs in Genetics to Date?
- How Is Bioinformatics Transforming the Medical Field? - When The Human Genome Project was completed in 2003, it signified one of the greatest scientific advancements in history, with researchers sequencing the human genome for the first time. The first draft produced a database of genetic variations that continue to have a growing impact on the medical field to this day. The development of … Continue reading How Is Bioinformatics Transforming the Medical Field?